We are live on ! Find out more
FOLD

Amicus Therapeutics
FOLD

Delisted

FOLD was delisted on the 24th of April, 2026.

Back to rankings

95 hedge funds and large institutions have $280M invested in Amicus Therapeutics in 2014 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 18 increasing their positions, 16 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

292% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 12

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

106% more capital invested

Capital invested by funds: $136M → $280M (+$144M)

69% more call options, than puts

Call options by funds: $4.08M | Put options by funds: $2.41M

58% more funds holding

Funds holding: 60 → 95 (+35)

13% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 16

Holders
95
Holders Change
+35
Holders Change %
+58.33%
% of All Funds
2.76%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
47
Increased
18
Reduced
16
Closed
12
Calls
$4.08M
Puts
$2.41M
Net Calls
+$1.67M
Net Calls Change
+$1.62M

Top Buyers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
+$9.81M
2
RIM
RS Investment Management
California
+$6.54M
3
BIM
Bogle Investment Management
Massachusetts
+$6.45M
4
Millennium Management
Millennium Management
New York
+$6.11M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$4.83M

Top Sellers

Rank Fund Capital Flow
1
PAI
Palo Alto Investors
California
-$10.6M
2
RG
Redmile Group
California
-$10.2M
3
SEP
Sound Energy Partners
Connecticut
-$2.11M
4
UBS AM
UBS AM
Illinois
-$2.03M
5
GTC
Ghost Tree Capital
New York
-$2M
Name Holding Trade Value Shares
Change 		Change in
Stake
NSEDCP
76
NJ State Employees Deferred Compensation Plan
New Jersey
$89K – – –
Charles Schwab
77
Charles Schwab
California
$83K – – –
BG
78
BlackRock Group
United Kingdom
$82K +$72.6K +13,854 New
OAM
79
Oxford Asset Management
United Kingdom
$79K +$69.5K +13,269 New
ST
80
Spot Trading
Illinois
$73K +$64.2K +12,260 New
BIM
81
BlackRock Investment Management
Delaware
$51K +$9.28K +1,772 +26%
Dimensional Fund Advisors
82
Dimensional Fund Advisors
Texas
$48K – – –
PCM
83
Prelude Capital Management
New York
$33K +$28.8K +5,500 New
BJ
84
BlackRock Japan
Japan
$30K +$26.1K +4,988 New
TRCT
85
Tower Research Capital (TRC)
New York
$24K +$8.87K +1,693 +73%
MA
86
MUFG Americas
New York
$18K +$15.9K +3,040 New
PNC Financial Services Group
87
PNC Financial Services Group
Pennsylvania
$12K -$31.4K -6,000 -75%
Creative Planning
88
Creative Planning
Kansas
$9K +$7.86K +1,500 New
QT
89
Quantbot Technologies
New York
$8K +$7.57K +1,444 New
TDC
90
Thompson Davis & Co
Virginia
$6K +$5.24K +1,000 New
SFPIA
91
Stevens First Principles Investment Advisors
California
$3K +$2.62K +500 New
Barclays
92
Barclays
United Kingdom
$1K -$226K -43,191 -100%
Citigroup
93
Citigroup
New York
$1K +$482 +92 New
AA
94
AlphaMark Advisors
Kentucky
$1K +$765 +146 New
Manulife (Manufacturers Life Insurance)
95
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
GTC
96
Ghost Tree Capital
New York
– -$2M -600,000 Closed
Jane Street
97
Jane Street
New York
– -$1.49M -446,057 Closed
Marshall Wace
98
Marshall Wace
United Kingdom
– -$1.13M -339,443 Closed
RA
99
Royce & Associates
New York
– -$948K -283,700 Closed
SM
100
Sabby Management
Florida
– -$334K -100,000 Closed
1 2 3
4
5

FOLD Hedge Fund Activity: Q3 2014 in Review

95 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Amicus Therapeutics (FOLD) for Q3 2014, worth a combined $280M — up 106% from $136M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new FOLD positions and 12 closed out — a net gain of 35 holders — while 18 added to existing stakes and 16 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $9.81M. The largest seller was Palo Alto Investors, cutting an estimated $10.6M.

  • 95 institutional investors held Amicus Therapeutics (FOLD) as of Q3 2014, up from 60 in Q2 2014.
  • Funds reported $280M of Amicus Therapeutics stock for Q3 2014, up 106% quarter-over-quarter.
  • 47 funds opened new Amicus Therapeutics positions in Q3 2014 and 12 closed out, a net change of +35 holders.
  • The largest Amicus Therapeutics buyer in Q3 2014 was Franklin Resources, an estimated $9.81M added.
  • The largest Amicus Therapeutics seller in Q3 2014 was Palo Alto Investors, an estimated $10.6M sold.

Based on aggregated 13F filings for Q3 2014.